Table 2.
Effect of Clinical and Demographic Factors on Allowed Amount Per Patient Per Episode
| Factor/Exposure | Group/Referent | (exp) Allowed Amount |
95% CI | p-value | Mean Amounts Group/Referent |
95% CI (Mean Amounts) Group/Referent) |
|---|---|---|---|---|---|---|
| Intercept | – | 237 | 231.8–242.3 | p < .001 | – | |
| Cohort | CoE/Network | 0.77 | 0.75–0.79 | p < .001 | $252/$326 | ($246 - $258)/($323 - $330) |
| Health Plan | Commercial/Gov’t | 1.49 | 1.47–1.52 | p < .001 | $350/ $235 | ($345 - $355)/ ($230 - $239) |
| Region | Urban/Rural | 1.23 | 1.21–1.25 | p < .001 | $318/$259 | ($313–$322)/($254 - $264) |
| Sex | Female/Male | 1.04 | 1.02–1.05 | p < .001 | $292/$282 | ($287–$296)/($277–$286) |
Note. Dependent Variable = Allowed Amount (positive expenditures modeled; N = 24,330). Exposure variables in this model include: Cohort, Health Plan, Region, and Sex (entered as factors in the GLM). maximum likelihood estimate
Exposure of interest/reference group (variable). Reference (or comparison) group is specified after the forward slash “/”
Mean (allowed) amounts presented for Group/Referent and 95% CIs (for mean allowed amounts) come from the GLM
model’s estimated mean